Pfizer
PFE
3,045 hedge funds and large institutions have $145B invested in Pfizer in 2023 Q2 according to their latest regulatory filings, with 145 funds opening new positions, 1,380 increasing their positions, 1,255 reducing their positions, and 180 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 1,380 | Existing positions reduced: 1,255
0.37% less ownership
Funds ownership: 69.91% → 69.54% (-0.37%)
1% less capital inflows, than outflows
Capital inflows: $6.76B | Capital outflows: $6.82B
2% less funds holding
Funds holding: 3,106 → 3,045 (-61)
19% less first-time investments, than exits
New positions opened: 145 | Existing positions closed: 180
27% less call options, than puts
Call options by funds: $1.73B | Put options by funds: $2.36B
36% less funds holding in top 10
Funds holding in top 10: 80 → 51 (-29)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$552M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$349M |
| 3 |
JP Morgan Chase
New York
|
+$282M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$260M |
| 5 |
Barclays
London,
United Kingdom
|
+$252M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.26B |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$1.06B |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$202M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$171M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$164M |
PFE Hedge Fund Activity: Q2 2023 in Review
3,045 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2023, worth a combined $145B — down 10% from $162B a quarter earlier.
Sellers outnumbered buyers: 180 funds closed out of PFE and 145 opened new positions — a net loss of 35 holders — while 1,255 trimmed existing stakes and 1,380 added.
The largest buyer was Wellington Management Group, adding an estimated $552M. The largest seller was Capital World Investors, cutting an estimated $1.26B.
- 3,045 institutional investors held Pfizer (PFE) as of Q2 2023, down from 3,106 in Q1 2023.
- Funds reported $145B of Pfizer stock for Q2 2023, down 10% quarter-over-quarter.
- 145 funds opened new Pfizer positions in Q2 2023 and 180 closed out, a net change of -35 holders.
- The largest Pfizer buyer in Q2 2023 was Wellington Management Group, an estimated $552M added.
- The largest Pfizer seller in Q2 2023 was Capital World Investors, an estimated $1.26B sold.
Based on aggregated 13F filings for Q2 2023.